🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05638191
Recruiting Observational

Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury

NCT05638191 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2021-06-03
Last updated
2026-05-29

Condition(s) studied

Spinal Cord InjurySpinal Cord Injury at C5-C7 LevelSCI - Spinal Cord InjuryUpper Extremity ParalysisUpper Extremity DysfunctionTetraplegiaUpper Extremity ParesisCervical Spinal Cord Injury

Investigational drug(s) / intervention(s)

Nerve transfer surgery

Nerve transfer surgery: The intervention in this study, which follows our clinical approach, is the "double nerve transfer" to restore grasp function (i.e., hand opening and hand closing). Finger and thumb extension (hand opening) is restored via the supinator-posterior interosseous nerve (PIN) transfer. Finger and thumb flexion (hand closing) is restored via a nerve transfer to the anterior interosseous nerve (AIN). There are two donor nerve options available to restore function to the muscles supplied by the AIN: the nerve to the brachialis and the nerve to the extensor carpi radialis longus (ECRL) or extensor carpi radialis brevis (ECRB).

Study summary

The goal of this prospective, open-label cohort study is to assess functional outcomes in individuals with cervical spinal cord injury who have undergone nerve transfer surgery to restore upper limb function. The main questions it aims to answer are:

* Does nerve transfer improve hand function in individuals with cervical spinal cord injury?
* What factors are associated with functional improvement following nerve transfer? Researchers will compare functional outcomes at 24 months post-surgery to 1) baseline outcomes and 2) individuals with cervical spinal cord injury who did not undergo nerve transfer.

Participants who have received nerve transfer surgery as part of their regular medical care will complete functional hand tests, electrodiagnostic assessments, and questionnaires on independence and mood every 3 months for 24 months after surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Traumatic, motor-complete cervical SCI (AIS A or B) * Male or female, ages 18-70 * Consent and plan to undergo nerve transfer to restore grasp function in at least one limb * Motor grade 4-5 at C5 * Motor grade 0-1 at C8/T1 * Injury duration within 6 months at the time of surgery * English-speaking and cognitively intact * Able to provide informed written consent * Able to attend and comply with the testing protocols Exclusion Criteria: * Inability or unwillingness to participate in post-operative rehabilitation (in person or virtual) * Secondary complication of SCI (e.g., intractable neuropathic pain, edema, contracture) or major medical comorbidity (e.g., traumatic brain injury) that would independently influence response to surgery or ability to participate in rehabilitation

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
GF Strong Rehabilitation Hospital Vancouver British Columbia Recruiting
QEII Health Sciences Centre Halifax Nova Scotia Recruiting
Kingston Health Sciences Centre Kingston Ontario Recruiting
Sunnybrook Health Sciences Centre Toronto Ontario Recruiting

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05638191 on ClinicalTrials.gov ↗ ← All trials in Canada